Eleftha 375mg+ Free Shipping
Eleftha 375mg Injection consists of the active ingredient Trastuzumab. It is indicated to treat early-stage and metastatic breast cancer where the cancer cells develop due to overexpression of HER2 proteins. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins. Cancer occurs when the cells begin to grow abnormally and uncontrollably, and cancer that has begun to spread is termed metastatic cancer
Eleftha 375 mg Injection is an intravenous infusion, administred under the supervision of your doctor or a nurse in a hospital. Self administration is not recommended to the patient.